⌘K

Login Start Free

Home/Insiders/Daniel Mark James

DM

SEC Insider//CIK 0002092593

Daniel Mark James

CIK 00020925931 companySEATTLE, WA

Transactions

2

Companies

1

Filings

2

CIK

0002092593

Recent Transactions

2 trades

Award
ATOSSA THERAPEUTICS, INC.$ATOS
Common Stock
2026-03-26+63,000→ 63,000 total
Award
ATOSSA THERAPEUTICS, INC.$ATOS
Stock Option (right to buy)
2025-10-14+578,000→ 578,000 total

Companies

1

ATOSSA THERAPEUTICS, INC.
Chief Financial Officer
$ATOS

Recent Filings

2

Address

C/O ATOSSA THERAPEUTICS, INC. 1448 NW MARKET STREET, SUITE 500

SEATTLE, WA, 98107

View on SEC.gov